Heart failure (HF), a common complication of myocardial infarction (MI), occurs in 14%-36% of hospitalized patients. Patients with HF can present with a wide spectrum of clinical severity, ranging ...

Objectives: The objectives of this drug utilization review programwere (1) to increase β-blocker prescribing to fee-for-servicepost-acute myocardial infarction (AMI) Medicaid patients; (2) ...

The largest analysis aimed at more accurately predicting the risk of sudden cardiac death after myocardial infarction is presented in late breaking results from the PROFID consortium at ESC Congress ...

When Asian dust clouds blow in to Japan's Kumamoto Prefecture, hospitals in the region handle a surge of acute myocardial infarctions (AMI) in the following 24 hours, and now a new prediction tool ...

Aspirin is a well-established therapy for the secondary prevention of cardiovascular events. However, its role in the primary prevention of cardiovascular disease is unclear, especially in older ...

Systemic lupus erythematosus is associated with higher risks for all-cause and cardiovascular mortality for up to 5 years after acute myocardial infarction, a study finds.

Two of the largest global studies on heart attack and stroke risk point to the same finding: most cardiovascular events trace back to a short list of modifiable factors, with diet sitting near the top ...

The largest analysis aimed at more accurately predicting the risk of sudden cardiac death after myocardial infarction is presented in late breaking results from the PROFID consortium at ESC Congress ...

Sophia Antipolis, France – 25 Aug 2021: The largest analysis aimed at more accurately predicting the risk of sudden cardiac death after myocardial infarction is presented in late breaking results from ...

The first clinical trial to challenge the routine implantation of a defibrillator in myocardial infarction survivors with heart failure has enrolled its first patient. The PROFID EHRA trial is part of ...